Program Code: SCF-DBI-PCICU-INFECT-0001**
Operational Window: Admission → Postoperative Recovery → Device Support → Transplant Recovery → Longitudinal Surveillance
Primary Objective: Prevent infection-mediated cardiovascular adaptation failure, preserve endothelial integrity, maintain immune competence, protect implanted devices and grafts, and optimize long-term cardiac recovery.
SECTION 14.1
CLINICAL POSITIONING
Traditional Cardiac Infection Prevention Model
Focuses on:
Surgical site infections
Device infections
Bloodstream infections
Antimicrobial therapy
Mortality reduction
SCF-DBI Cardiovascular Infection Model
Infections are viewed as:
Secondary Cardiovascular Biological Intelligence Disruptors
capable of producing:
Neuroimmune destabilization
Endothelial injury
Myocardial dysfunction
Graft injury
Recovery interruption
Core Principle
Every prevented infection preserves cardiovascular adaptation and recovery intelligence.
SECTION 14.2
RHENOVA CARDIAC INFECTION PREDICTION ENGINE (CIPE)
Strategic Objective
Identify infection risk before overt clinical manifestation.
Risk Domain 1
Host Vulnerability
Immune competence
Age
Chronic disease burden
STRI
Risk Domain 2
Cardiac Device Burden
Central lines
Pacing wires
ECMO
VAD
Prosthetic materials
Risk Domain 3
Transplant Vulnerability
Immunosuppression intensity
Rejection treatment burden
T-STRI
Risk Domain 4
Recovery Vulnerability
Nutrition
Mobility
Recovery delays
Primary Output
Cardiac Infection Risk Probability Score (CIRPS)
SECTION 14.3
CARDIAC SURGICAL SITE INFECTION (SSI) PREVENTION SOP
Strategic Position
Postoperative infections threaten:
Surgical repair integrity
Hemodynamic adaptation
Endothelial recovery
Neurodevelopment
Prevention Components
Sterile technique compliance
Perioperative antimicrobial stewardship
Glycemic optimization
Perfusion optimization
Wound surveillance
Daily Assessment
Wound integrity
Drainage
Inflammatory markers
Recovery trajectory
SECTION 14.4
POST-STERNOTOMY INFECTION PREVENTION PROGRAM
High-Risk Populations
Neonatal surgery
Delayed sternal closure
ECMO-supported patients
Reoperation patients
Monitoring Domains
Wound healing
Mediastinal integrity
Endothelial recovery
Immune competence
Escalation Indicators
Fever
Wound changes
Recovery deterioration
STRI decline
SECTION 14.5
CARDIAC DEVICE INFECTION PREVENTION FRAMEWORK
Covered Devices
Temporary pacing wires
Permanent pacemakers
ICD systems
Central venous catheters
VAD systems
ECMO circuits
Prevention Objectives
Device integrity
Infection prevention
Recovery preservation
Monitoring Variables
Device function
Site assessment
Blood cultures
Recovery progression
SECTION 14.6
ECMO/VAD INFECTION SURVEILLANCE PROGRAM
Clinical Positioning
Extracorporeal support increases prolonged infection risk.
Surveillance Domains
Cannulation site infection
Bloodstream infection
Device colonization
Immune adaptation
Monitoring Variables
Cultures
Procalcitonin
CRP
STRI
ANMS
Escalation Triggers
Persistent inflammatory activation
Positive cultures
Recovery delay
EII decline >15%
SECTION 14.7
CARDIAC TRANSPLANT INFECTION PREVENTION PLATFORM
Clinical Positioning
Transplant recipients require preservation of:
Immune competence
while maintaining:
Rejection prevention
High-Risk Periods
Immediate Post-Transplant
0–30 Days
Intermediate Risk
30–180 Days
Long-Term Surveillance
180 Days
Monitoring Domains
Opportunistic infections
Viral surveillance
Fungal surveillance
T-STRI
IAI
SECTION 14.8
ENDOCARDITIS PREVENTION & EARLY DETECTION PROGRAM
High-Risk Populations
Prosthetic valves
Complex congenital heart disease
Prior endocarditis
Transplant recipients
Early Detection Variables
Fever
New murmur
Positive cultures
Echocardiographic findings
Recovery deterioration
Primary Output
Endocarditis Adaptation Risk Score (EARS)
SECTION 14.9
CARDIOVASCULAR IMMUNE RESILIENCE FRAMEWORK
Strategic Objective
Maintain host defense while supporting cardiovascular recovery.
Core Domains
Immune Competence
Endothelial Recovery
Myocardial Recovery
Self-Tolerance Preservation
Functional Recovery
Primary Output
Cardiovascular Immune Resilience Score (CIRS)
SECTION 14.10
ENDOTHELIAL-INFECTION INTERACTION FRAMEWORK
Clinical Positioning
Endothelial injury amplifies infection-related morbidity.
Surveillance Domains
Glycocalyx integrity
Perfusion
Microvascular adaptation
Organ oxygen delivery
Monitoring Variables
EII
Lactate
Tissue oxygenation
Recovery trajectory
SECTION 14.11
CARDIAC INFECTION ANMS FRAMEWORK
Neuroimmune Domain
Monitor:
Infection burden
Cytokine burden
STRI
Neurocardiac Domain
Monitor:
Ventricular performance
Perfusion
Arrhythmia burden
Neurovascular Domain
Monitor:
Endothelial integrity
EII
Neurometabolic Domain
Monitor:
Lactate
Nutritional adaptation
Neuroendocrine Domain
Monitor:
Stress burden
Recovery reserve
SECTION 14.12
OUTBREAK DETECTION & CONTAINMENT FRAMEWORK
Trigger Events
Clustered bloodstream infections
Device-related infection increase
Resistant organism emergence
Surgical site infection increase
Response Levels
Level 1
Enhanced Surveillance
Level 2
Focused Investigation
Level 3
Containment Activation
Level 4
Unit-Wide Response
SECTION 14.13
INFECTION ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
Early inflammatory activation
Recovery slowing
Level 2
Focused Investigation
Triggers:
Device infection suspicion
CIRPS elevation
STRI decline >15%
Level 3
Multidisciplinary Escalation
Triggers:
Confirmed infection
Ventricular dysfunction
EII decline >20%
Level 4
Advanced Rescue Activation
Triggers:
Sepsis
Shock
ANMS <40
SECTION 14.14
LONGITUDINAL CARDIOVASCULAR INFECTION SURVEILLANCE
Monitoring Timeline
ICU Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
↓
Annual Surveillance
Surveillance Domains
Infection recurrence
Device integrity
Endothelial recovery
Myocardial recovery
Functional recovery
SECTION 14.15
INFECTION PREVENTION SUCCESS ENDPOINTS
Clinical
Reduced bloodstream infections
Reduced device infections
Reduced sternotomy infections
Reduced endocarditis
Recovery
Reduced ICU LOS
Reduced rehospitalization
Improved recovery trajectories
Biological Intelligence
ANMS >80
STRI >80
EII >80
CIRS >80
Sustained cardiovascular adaptation
PAGE 14 COMPLETION
Next Page (Page 15):